EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma

Katie E Hebron iD, Patience Odeniyide iD, Yun Wei iD, Berkley E Gryder iD, Frederic G Barr, Dana L Casey, Eleanor Y Chen iD, Brian D Crompton, Filemon S Dela Cruz iD, Adam D Durbin iD, Heide L Ford, Susanne A Gatz iD und 28 weitere

Cancers · 10.03.2026 · 18 (6) · 888

DOI: 10.3390/cancers18060888 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 10.03.2026. Verfasst von Katie E Hebron und 39 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cell and Developmental Signaling, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21701, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Intramural Research Program of the National Institutes of Health, Summer’s Way and Friends of TJ Young Investigator Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite comprehensive and multi-modal therapy, outcomes for children and adolescents with rhabdomyosarcoma (RMS) have plateaued over the past four decades. This is not for a lack of progress in the basic and translational studies of RMS. Indeed, advances in animal models and/or patient tissue sample acquisition and analysis have improved our understanding of RMS biology. Large-scale sequencing efforts have generated transcriptomic, genomic, and epigenomic datasets that highlight the heterogeneity of RMS and have the potential to improve prognostication and the application of precision medicine in patients with RMS. However, few of these discoveries have been clinically translated, and limitations to the accessibility, uniformity, and application of these new models and datasets hinder their utility. Here, we discuss how advances in understanding RMS biology, optimization of preclinical models, and strategies for translating basic science discoveries to the clinic can potentially improve outcomes for patients with RMS.

Schlagwörter

Stichwörter der Autor:innen

animal modelscells of originpediatric sarcomaskeletal muscle malignancytumor heterogeneity

Autor:innen und Institutionen

  • Laboratory of Cell and Developmental Signaling, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21701, USA.
  • Basic Medical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN 47906, USA.
  • Division of Pediatric Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • Molecular Pathology Unit, Massachusetts General Research Institute, Harvard Medical School, Charlestown, MA 02129, USA.
  • Krantz Family Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA 02129, USA.
  • Division of Hematology and Oncology, Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX 75390, USA.

ORCID-Profile: Katie E Hebron, Patience Odeniyide, Yun Wei, Berkley E Gryder, Eleanor Y Chen, Filemon S Dela Cruz, Adam D Durbin, Susanne A Gatz, Mark E Hatley, Simone Hettmer, Genevieve C Kendall, Javed Khan, Philip J Lupo, Anand G Patel, Silvia Pomella, Rossella Rota, Jack F Shern, Benjamin Z Stanton, Christine M Heske, Corinne M Linardic

Förderung

  • NCI NIH HHS
  • Intramural Research Program of the National Institutes of Health
  • Summer’s Way and Friends of TJ Young Investigator Award
  • Alex’s Lemonade Stand Foundation
  • Italian Ministry of Health Ricerca Finalizzata 2021
  • Associazione Italiana Ricerca sul Cancro
  • NCI, Hyundai Hope on Wheels foundation
  • NIH

Zitieren

APA

Hebron, K. E., Odeniyide, P., Wei, Y., Gryder, B. E., Barr, F. G., Casey, D. L., Chen, E. Y., Crompton, B. D., Dela Cruz, F. S., Durbin, A. D., Ford, H. L., Gatz, S. A., Hatley, M. E., Henssen, A. G., Hettmer, S., Houghton, P. J., Kendall, G. C., Khan, J., Lupo, P. J., …, & Yohe, M. E. (2026). Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma. Cancers, 18(6), 888. https://doi.org/10.3390/cancers18060888

Vancouver

Hebron KE, Odeniyide P, Wei Y, Gryder BE, Barr FG, Casey DL, et al. Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma. Cancers. 2026;18(6):888. doi:10.3390/cancers18060888

BibTeX
@article{Hebron2026,
  author = {Hebron, Katie E and Odeniyide, Patience and Wei, Yun and Gryder, Berkley E and Barr, Frederic G and Casey, Dana L and Chen, Eleanor Y and Crompton, Brian D and Dela Cruz, Filemon S and Durbin, Adam D and Ford, Heide L and Gatz, Susanne A and Hatley, Mark E and Henssen, Anton G and Hettmer, Simone and Houghton, Peter J and Kendall, Genevieve C and Khan, Javed and Lupo, Philip J and Patel, Anand G and Pomella, Silvia and Rota, Rossella and Schito, Marco and Schoot, Reineke A and Shern, Jack F and Stanton, Benjamin Z and Stewart, Elizabeth A and Swindlehurst, Cathy A and Thomas, Craig J and Vakoc, Christopher R and Vaseva, Angelina V and Venkatramani, Rajkumar and Wexler, Leonard H and Yustein, Jason T and Hammond, Sharon and Heske, Christine M and Langenau, David M and Linardic, Corinne M and Ignatius, Myron S and Yohe, Marielle E},
  title = {Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {6},
  pages = {888},
  doi = {10.3390/cancers18060888}
}
Kostenlos starten →